{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T18:15:15Z","timestamp":1770747315343,"version":"3.49.0"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,9]]},"DOI":"10.7759\/cureus.103320","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T05:52:06Z","timestamp":1770702726000},"source":"Crossref","is-referenced-by-count":0,"title":["Hypertension Management Beyond Blood Pressure Control in India: An Expert Consensus on Angiotensin II Receptor Blocker and Calcium Channel Blocker Combination Therapy With Reference to Telmisartan and Cilnidipine"],"prefix":"10.7759","author":[{"given":"Jagdish","family":"Hiremath","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashok","family":"Kirpalani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deodatta","family":"Chafekar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. B","family":"Jayagopal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saumitra","family":"Ray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V. K","family":"Chopra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sameer","family":"Dani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamlakar","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. P. S","family":"Sawhney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abraham","family":"Oomman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil","family":"Sathe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jabir","family":"Abdullakutty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vijay","family":"Kher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepak","family":"Dewan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamal","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mukesh","family":"Shete","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. S","family":"Vali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjay","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Onkar C","family":"Swami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Global report on hypertension. the race against a silent killer. (2023). https:\/\/www.who.int\/publications\/i\/item\/9789240081062."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(23)00119-5","article-title":"Metabolic non-communicable disease health report of India: the ICMR-INDIAB national cross-sectional study (ICMR-INDIAB-17)","author":"Anjana RM","year":"202311","unstructured":"Anjana RM, Unnikrishnan R, Deepa M, et al.. Metabolic non-communicable disease health report of India: the ICMR-INDIAB national cross-sectional study (ICMR-INDIAB-17). Lancet Diabetes Endocrinol. 202311, 474-89. 10.1016\/S2213-8587(23)00119-5","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref3","unstructured":"Government of India Ministry of Health and Family Welfare. National Family Health Survey (NFHS-5) 2019-21. (2021). Accessed. February 5, 2026: https:\/\/main.mohfw.gov.in\/sites\/default\/files\/NFHS-5_Phase-II_0.pdf."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.lansea.2022.100113","article-title":"Hypertension control rate in India: systematic review and meta-analysis of population-level non-interventional studies, 2001-2022","volume":"9","author":"Koya SF","year":"2023","unstructured":"Koya SF, Pilakkadavath Z, Chandran P, Wilson T, Kuriakose S, Akbar SK, Ali A. Hypertension control rate in India: systematic review and meta-analysis of population-level non-interventional studies, 2001-2022. Lancet Reg Health Southeast Asia. 2023, 9:100113. 10.1016\/j.lansea.2022.100113","journal-title":"Lancet Reg Health Southeast Asia"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.122.321762","article-title":"Hypertension as cardiovascular risk factor in chronic kidney disease","volume":"132","author":"Burnier M","year":"2023","unstructured":"Burnier M, Damianaki A. Hypertension as cardiovascular risk factor in chronic kidney disease. Circ Res. 2023, 132:1050-63. 10.1161\/CIRCRESAHA.122.321762","journal-title":"Circ Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.4103\/jrms.jrms_470_23","article-title":"The connection between hypertension and diabetes and their role in heart and kidney disease development","volume":"29","author":"Hezam AA","year":"2024","unstructured":"Hezam AA, Shaghdar HB, Chen L. The connection between hypertension and diabetes and their role in heart and kidney disease development. J Res Med Sci. 2024, 29:22. 10.4103\/jrms.jrms_470_23","journal-title":"J Res Med Sci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2016.3667","article-title":"Obesity and hypertension","volume":"12","author":"Jiang SZ","year":"2016","unstructured":"Jiang SZ, Lu W, Zong XF, Ruan HY, Liu Y. Obesity and hypertension. Exp Ther Med. 2016, 12:2395-9. 10.3892\/etm.2016.3667","journal-title":"Exp Ther Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s12958-025-01431-x","article-title":"Obstructive sleep apnea-associated hypertensive disorders in pregnancy: a literature review and clinical management strategies","volume":"23","author":"Tang WZ","year":"2025","unstructured":"Tang WZ, Huang KJ, Xu HY, et al.. Obstructive sleep apnea-associated hypertensive disorders in pregnancy: a literature review and clinical management strategies. Reprod Biol Endocrinol. 2025, 23:114. 10.1186\/s12958-025-01431-x","journal-title":"Reprod Biol Endocrinol"},{"key":"ref9","doi-asserted-by":"crossref","DOI":"10.1016\/j.numecd.2023.07.010","article-title":"The causal associations of non-alcoholic fatty liver disease with blood pressure and the mediating effects of cardiometabolic risk factors: A Mendelian randomization study","volume":"33","author":"Zhang Z","year":"2023","unstructured":"Zhang Z, Li L, Hu Z, Zhou L, Zhang Z, Xiong Y, Yao Y. The causal associations of non-alcoholic fatty liver disease with blood pressure and the mediating effects of cardiometabolic risk factors: A Mendelian randomization study. Nutr Metab Cardiovasc Dis. 2023, 33:2151-9.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehae178","article-title":"2024 ESC Guidelines for the management of elevated blood pressure and hypertension: Developed by the task force on the management of elevated blood pressure and hypertension of the European Society of Cardiology (ESC) and endorsed by the European Society of Endocrinology (ESE) and the European Stroke Organisation (ESO)","volume":"45","author":"McEvoy JW","year":"2024","unstructured":"McEvoy JW, McCarthy CP, Bruno RM, et al.. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension: Developed by the task force on the management of elevated blood pressure and hypertension of the European Society of Cardiology (ESC) and endorsed by the European Society of Endocrinology (ESE) and the European Stroke Organisation (ESO). Eur Heart J. 2024, 45:3912-4018. 10.1093\/eurheartj\/ehae178","journal-title":"Eur Heart J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s13410-022-01143-7","article-title":"RSSDI Guidelines for the management of hypertension in patients with diabetes mellitus","volume":"42","author":"Kumar V","year":"2022","unstructured":"Kumar V, Agarwal S, Saboo B, Makkar B. RSSDI Guidelines for the management of hypertension in patients with diabetes mellitus. Int J Diabetes Dev Ctries. 2022, 42:576-605. 10.1007\/s13410-022-01143-7","journal-title":"Int J Diabetes Dev Ctries"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1161\/HYP.0000000000000080","article-title":"Correction to: 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APHA\/ash\/ASPC\/NMA\/PCNA guideline for the Prevention, Detection, Evaluation, and management of high blood pressure in adults: Executive Summary: A report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines","volume":"72","author":"Whelton PK","year":"2018","unstructured":"Whelton PK, Carey RM, Aronow WS, et al.. Correction to: 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APHA\/ash\/ASPC\/NMA\/PCNA guideline for the Prevention, Detection, Evaluation, and management of high blood pressure in adults: Executive Summary: A report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines. Hypertension. 2018, 72:e33. 10.1161\/HYP.0000000000000080","journal-title":"Hypertension"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.61081\/htnj\/23v9i302","article-title":"InSH consensus guideline for the management of hypertension","volume":"2023","author":"Gupta R","year":"2023","unstructured":"Gupta R, Maheshwari A, Verma N, et al.. InSH consensus guideline for the management of hypertension. Hypertension J. 2023, 2023:57-132. 10.61081\/htnj\/23v9i302","journal-title":"Hypertension J"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.120.15026","article-title":"2020 International Society of Hypertension Global hypertension practice guidelines","volume":"75","author":"Unger T","year":"2020","unstructured":"Unger T, Borghi C, Charchar F, et al.. 2020 International Society of Hypertension Global hypertension practice guidelines. Hypertension. 2020, 75:1334-57. 10.1161\/HYPERTENSIONAHA.120.15026","journal-title":"Hypertension"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.121.18502","article-title":"Hypertension-mediated organ damage: prevalence, correlates, and prognosis in the community","volume":"79","author":"Vasan RS","year":"2022","unstructured":"Vasan RS, Song RJ, Xanthakis V, Beiser A, DeCarli C, Mitchell GF, Seshadri S. Hypertension-mediated organ damage: prevalence, correlates, and prognosis in the community. Hypertension. 2022, 79:505-15. 10.1161\/HYPERTENSIONAHA.121.18502","journal-title":"Hypertension"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.4103\/ijmr.ijmr_3096_21","article-title":"The Indian registry on current patient profiles and treatment trends in hypertension (RECORD): one year interim analysis","volume":"158","author":"Rajadhyaksha GC","year":"2023","unstructured":"Rajadhyaksha GC, Reddy H, Singh AK, Oomman A, Adhyapak SM. The Indian registry on current patient profiles and treatment trends in hypertension (RECORD): one year interim analysis. Indian J Med Res. 2023, 158:244-55. 10.4103\/ijmr.ijmr_3096_21","journal-title":"Indian J Med Res"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.19590","article-title":"Treatment of hypertension: a review","volume":"328","author":"Carey RM","year":"2022","unstructured":"Carey RM, Moran AE, Whelton PK. Treatment of hypertension: a review. J Am Med Assoc. 2022, 328:1849-61. 10.1001\/jama.2022.19590","journal-title":"J Am Med Assoc"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-048079","article-title":"Non-pharmacological interventions to achieve blood pressure control in African patients: a systematic review","volume":"12","author":"Cernota M","year":"2022","unstructured":"Cernota M, Kroeber ES, Demeke T, et al.. Non-pharmacological interventions to achieve blood pressure control in African patients: a systematic review. BMJ Open. 2022, 12:e048079. 10.1136\/bmjopen-2020-048079","journal-title":"BMJ Open"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2023.10.018","article-title":"KDIGO 2024 clinical practice Guideline for the evaluation and management of chronic kidney disease","volume":"105","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group","year":"2024","unstructured":"Kidney Disease. Improving Global Outcomes (KDIGO) CKD Work Group: KDIGO 2024 clinical practice Guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2024, 105:S117-314. 10.1016\/j.kint.2023.10.018","journal-title":"Kidney Int"},{"key":"ref20","doi-asserted-by":"crossref","DOI":"10.1093\/ajh\/hpad101","article-title":"Effect of heart-healthy dietary patterns on blood pressure: a systematic review and meta-analysis","volume":"37","author":"Jiao X","year":"2024","unstructured":"Jiao X, Song K, Zhang N, et al.. Effect of heart-healthy dietary patterns on blood pressure: a systematic review and meta-analysis. Am J Hypertens. 2024, 37:239.","journal-title":"Am J Hypertens"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3390\/nu15143261","article-title":"Adherence to the DASH diet and risk of hypertension: a systematic review and meta-analysis","volume":"15","author":"Theodoridis X","year":"2023","unstructured":"Theodoridis X, Chourdakis M, Chrysoula L, et al.. Adherence to the DASH diet and risk of hypertension: a systematic review and meta-analysis. Nutrients. 2023, 15:3261. 10.3390\/nu15143261","journal-title":"Nutrients"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2105675","article-title":"Effect of salt substitution on cardiovascular events and death","volume":"385","author":"Neal B","year":"2021","unstructured":"Neal B, Wu Y, Feng X, et al.. Effect of salt substitution on cardiovascular events and death. N Engl J Med. 2021, 385:1067-77. 10.1056\/NEJMoa2105675","journal-title":"N Engl J Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m315","article-title":"Effect of dose and duration of reduction in dietary sodium on blood pressure levels: systematic review and meta-analysis of randomised trials","volume":"368","author":"Huang L","year":"2020","unstructured":"Huang L, Trieu K, Yoshimura S, et al.. Effect of dose and duration of reduction in dietary sodium on blood pressure levels: systematic review and meta-analysis of randomised trials. Br Med J. 2020, 368:m315. 10.1136\/bmj.m315","journal-title":"Br Med J"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.015719","article-title":"Potassium intake and blood pressure: a dose-response meta-analysis of randomized controlled trials","volume":"9","author":"Filippini T","year":"2020","unstructured":"Filippini T, Naska A, Kasdagli MI, et al.. Potassium intake and blood pressure: a dose-response meta-analysis of randomized controlled trials. J Am Heart Assoc. 2020, 9:e015719. 10.1161\/JAHA.119.015719","journal-title":"J Am Heart Assoc"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/jch.14661","article-title":"Effect of weight loss on blood pressure changes in overweight patients: a systematic review and meta-analysis","volume":"25","author":"Yang S","year":"2023","unstructured":"Yang S, Zhou Z, Miao H, Zhang Y. Effect of weight loss on blood pressure changes in overweight patients: a systematic review and meta-analysis. J Clin Hypertens (Greenwich). 2023, 25:404-15. 10.1111\/jch.14661","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.18332\/tid\/186853","article-title":"Smoking cessation decreases arterial blood pressure in hypertensive smokers: a subgroup analysis of the randomized controlled trial GENTSMOKING","volume":"22","author":"Gaya PV","year":"2024","unstructured":"Gaya PV, Fonseca GW, Tanji LT, et al.. Smoking cessation decreases arterial blood pressure in hypertensive smokers: a subgroup analysis of the randomized controlled trial GENTSMOKING. Tob Induc Dis. 2024, 22:80. 10.18332\/tid\/186853","journal-title":"Tob Induc Dis"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.124.22703","article-title":"Alcohol intake and risk of hypertension: a systematic review and dose-response meta-analysis of nonexperimental cohort studies","volume":"81","author":"Cecchini M","year":"2024","unstructured":"Cecchini M, Filippini T, Whelton PK, Iamandii I, Di Federico S, Boriani G, Vinceti M. Alcohol intake and risk of hypertension: a systematic review and dose-response meta-analysis of nonexperimental cohort studies. Hypertension. 2024, 81:1701-15. 10.1161\/HYPERTENSIONAHA.124.22703","journal-title":"Hypertension"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1007\/s00394-017-1591-z","article-title":"Coffee consumption and risk of hypertension: a dose-response meta-analysis of prospective studies","volume":"58","author":"D'Elia L","year":"2019","unstructured":"D'Elia L, La Fata E, Galletti F, Scalfi L, Strazzullo P. Coffee consumption and risk of hypertension: a dose-response meta-analysis of prospective studies. Eur J Nutr. 2019, 58:271-80. 10.1007\/s00394-017-1591-z","journal-title":"Eur J Nutr"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.011318","article-title":"Impact of high volume energy drink consumption on electrocardiographic and blood pressure parameters: a randomized trial","volume":"8","author":"Shah SA","year":"2019","unstructured":"Shah SA, Szeto AH, Farewell R, et al.. Impact of high volume energy drink consumption on electrocardiographic and blood pressure parameters: a randomized trial. J Am Heart Assoc. 2019, 8:e011318. 10.1161\/JAHA.118.011318","journal-title":"J Am Heart Assoc"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-020-02511-9","article-title":"Sugar-sweetened beverages increases the risk of hypertension among children and adolescence: a systematic review and dose-response meta-analysis","volume":"18","author":"Farhangi MA","year":"2020","unstructured":"Farhangi MA, Nikniaz L, Khodarahmi M. Sugar-sweetened beverages increases the risk of hypertension among children and adolescence: a systematic review and dose-response meta-analysis. J Transl Med. 2020, 18:344. 10.1186\/s12967-020-02511-9","journal-title":"J Transl Med"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jshs.2024.01.004","article-title":"The effectiveness of physical activity interventions on blood pressure in children and adolescents: a systematic review and network meta-analysis","volume":"13","author":"Hassan MA","year":"2024","unstructured":"Hassan MA, Zhou W, Ye M, He H, Gao Z. The effectiveness of physical activity interventions on blood pressure in children and adolescents: a systematic review and network meta-analysis. J Sport Health Sci. 2024, 13:699-708. 10.1016\/j.jshs.2024.01.004","journal-title":"J Sport Health Sci"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1038\/s41440-023-01467-9","article-title":"Effects of aerobic exercise on blood pressure in patients with hypertension: a systematic review and dose-response meta-analysis of randomized trials","volume":"47","author":"Jabbarzadeh Ganjeh B","year":"2024","unstructured":"Jabbarzadeh Ganjeh B, Zeraattalab-Motlagh S, Jayedi A, et al.. Effects of aerobic exercise on blood pressure in patients with hypertension: a systematic review and dose-response meta-analysis of randomized trials. Hypertens Res. 2024, 47:385-98. 10.1038\/s41440-023-01467-9","journal-title":"Hypertens Res"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1136\/bjsports-2022-106503","article-title":"Exercise training and resting blood pressure: a large-scale pairwise and network meta-analysis of randomised controlled trials","volume":"57","author":"Edwards JJ","year":"2023","unstructured":"Edwards JJ, Deenmamode AH, Griffiths M, Arnold O, Cooper NJ, Wiles JD, O'Driscoll JM. Exercise training and resting blood pressure: a large-scale pairwise and network meta-analysis of randomised controlled trials. Br J Sports Med. 2023, 57:1317-26. 10.1136\/bjsports-2022-106503","journal-title":"Br J Sports Med"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaim.2023.100882","article-title":"Yoga Nidra for hypertension: a systematic review and meta-analysis","volume":"15","author":"Ahuja N","year":"2024","unstructured":"Ahuja N, Bhardwaj P, Pathania M, et al.. Yoga Nidra for hypertension: a systematic review and meta-analysis. J Ayurveda Integr Med. 2024, 15:100882. 10.1016\/j.jaim.2023.100882","journal-title":"J Ayurveda Integr Med"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2018.09.023","article-title":"Yoga as antihypertensive lifestyle therapy: a systematic review and meta-analysis","volume":"94","author":"Wu Y","year":"2019","unstructured":"Wu Y, Johnson BT, Acabchuk RL, et al.. Yoga as antihypertensive lifestyle therapy: a systematic review and meta-analysis. Mayo Clin Proc. 2019, 94:432-46. 10.1016\/j.mayocp.2018.09.023","journal-title":"Mayo Clin Proc"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-024-03746-w","article-title":"Effect of mindfulness-based interventions on people with prehypertension or hypertension: a systematic review and meta-analysis of randomized controlled trials","volume":"24","author":"Chen Q","year":"2024","unstructured":"Chen Q, Liu H, Du S. Effect of mindfulness-based interventions on people with prehypertension or hypertension: a systematic review and meta-analysis of randomized controlled trials. BMC Cardiovasc Disord. 2024, 24:104. 10.1186\/s12872-024-03746-w","journal-title":"BMC Cardiovasc Disord"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.7573\/dic.212531","article-title":"Combination therapy in the treatment of hypertension","volume":"7","author":"Guerrero-Garc\u00eda C","year":"2018","unstructured":"Guerrero-Garc\u00eda C, Rubio-Guerra AF. Combination therapy in the treatment of hypertension. Drugs Context. 2018, 7:212531. 10.7573\/dic.212531","journal-title":"Drugs Context"},{"key":"ref38","article-title":"Managing hypertension using combination therapy","volume":"101","author":"Smith DK","year":"2020","unstructured":"Smith DK, Lennon RP, Carlsgaard PB. Managing hypertension using combination therapy. Am Fam Physician. 2020, 101:341-9.","journal-title":"Am Fam Physician"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2023.0720","article-title":"Efficacy and safety of low-dose triple and quadruple combination pills vs monotherapy, usual care, or placebo for the initial management of hypertension: a systematic review and meta-analysis","volume":"8","author":"Wang N","year":"2023","unstructured":"Wang N, Rueter P, Atkins E, et al.. Efficacy and safety of low-dose triple and quadruple combination pills vs monotherapy, usual care, or placebo for the initial management of hypertension: a systematic review and meta-analysis. JAMA Cardiol. 2023, 8:606-11. 10.1001\/jamacardio.2023.0720","journal-title":"JAMA Cardiol"},{"key":"ref40","article-title":"The current update on the efficacy of Telmisartan in patients with hypertension: a systematic review.","author":"Pinakesty A","year":"2022","unstructured":"Pinakesty A, Saputra RC, Anggraeni Y, Mahmuda IN. The current update on the efficacy of Telmisartan in patients with hypertension: a systematic review.. Advances in Health Sciences Research: Proceedings of the 3rd International Conference on Cardiovascular Diseases (ICCvD). Atlantis Press, Dordrecht, Netherlands; 2022. 47-10."},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.4103\/jfmpc.jfmpc_787_22","article-title":"Blood pressure-lowering effect of telmisartan compared to losartan among mild to moderate essential hypertensive adult subjects: a meta-analysis","volume":"11","author":"Kumari K","year":"2022","unstructured":"Kumari K, Toppo MS, Majhi L, Kumar A. Blood pressure-lowering effect of telmisartan compared to losartan among mild to moderate essential hypertensive adult subjects: a meta-analysis. J Family Med Prim Care. 2022, 11:6227-35. 10.4103\/jfmpc.jfmpc_787_22","journal-title":"J Family Med Prim Care"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.16797","article-title":"Effect of Telmisartan on walking performance in patients with lower extremity peripheral artery disease: the TELEX  randomized clinical trial","volume":"328","author":"McDermott MM","year":"2022","unstructured":"McDermott MM, Bazzano L, Peterson CA, et al.. Effect of Telmisartan on walking performance in patients with lower extremity peripheral artery disease: the TELEX  randomized clinical trial. J Am Med Assoc. 2022, 328:1315-25. 10.1001\/jama.2022.16797","journal-title":"J Am Med Assoc"},{"key":"ref43","article-title":"An open label prospective study on evaluation of safety and efficacy of cilnidipine over amlodipine in Stage 1 hypertensive patients","volume":"18","author":"Harlalka S","year":"2020","unstructured":"Harlalka S, Roy UK, Majumdar G, Das K, Mandal P . An open label prospective study on evaluation of safety and efficacy of cilnidipine over amlodipine in Stage 1 hypertensive patients. Kathmandu Univ Med J (KUMJ). 2020, 18:42-8.","journal-title":"Kathmandu Univ Med J (KUMJ)"},{"key":"ref44","article-title":"A randomized open-label parallel-group study comparing the efficacy and safety of cilnidipine and amlodipine in hypertensive adults","volume":"69","author":"Jj NK","year":"2022","unstructured":"Jj NK, D DC, Kavitha R. A randomized open-label parallel-group study comparing the efficacy and safety of cilnidipine and amlodipine in hypertensive adults. J Assoc Physicians India. 2022, 69:11-2.","journal-title":"J Assoc Physicians India"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.19822","article-title":"Efficacy of cilnidipine (L\/N-type calcium channel blocker) in treatment of hypertension: a meta-analysis of randomized and non-randomized controlled trials","volume":"13","author":"Chakraborty RN","year":"2021","unstructured":"Chakraborty RN, Langade D, More S, Revandkar V, Birla A. Efficacy of cilnidipine (L\/N-type calcium channel blocker) in treatment of hypertension: a meta-analysis of randomized and non-randomized controlled trials. Cureus. 2021, 13:e19822. 10.7759\/cureus.19822","journal-title":"Cureus"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.14740\/cr1476","article-title":"A prospective, randomized open-label study for assessment of antihypertensive effect of Telmisartan versus cilnidipine using ambulatory blood pressure monitoring (START ABPM study)","volume":"14","author":"Sawant R","year":"2023","unstructured":"Sawant R, Suryawanshi S, Jadhav M, Barkate H, Bhushan S, Rane T. A prospective, randomized open-label study for assessment of antihypertensive effect of Telmisartan versus cilnidipine using ambulatory blood pressure monitoring (START ABPM study). Cardiol Res. 2023, 14:211-20. 10.14740\/cr1476","journal-title":"Cardiol Res"},{"key":"ref47","article-title":"Comparison of cilnidipine and telmisartan in the management of hypertensive patients attending a tertiary care teaching hospital.","volume":"14","author":"Sayeli V","year":"2023","unstructured":"Sayeli V, Pokala U, Rayam S. Comparison of cilnidipine and telmisartan in the management of hypertensive patients attending a tertiary care teaching hospital.. J Cardiovasc Dis Res. 2023, 14:571-5.","journal-title":"J Cardiovasc Dis Res"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2021.12.030","article-title":"Achieving the latest American Heart Association and American College of Cardiology therapeutic goals for hypertension with combination therapy and its effects on blood pressure and central hemodynamic parameters","volume":"168","author":"Ram CV","year":"2022","unstructured":"Ram CV, Muppalla BS, Parthasaradhi SV, et al.. Achieving the latest American Heart Association and American College of Cardiology therapeutic goals for hypertension with combination therapy and its effects on blood pressure and central hemodynamic parameters. Am J Cardiol. 2022, 168:78-82. 10.1016\/j.amjcard.2021.12.030","journal-title":"Am J Cardiol"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.18203\/2349-3933.ijam20243058","article-title":"Assessing cilnidipine and its combination usage in Indian settings: a knowledge, attitude, and practice survey","volume":"11","author":"Shete M","year":"2024","unstructured":"Shete M, Saxena A, Nakrani A, Shah C, Bhojwani H, Jiwane D. Assessing cilnidipine and its combination usage in Indian settings: a knowledge, attitude, and practice survey. Int J Adv Med. 2024, 11:559-65. 10.18203\/2349-3933.ijam20243058","journal-title":"Int J Adv Med"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehac395","article-title":"Hypertension management in patients with cardiovascular comorbidities","volume":"44","author":"Lauder L","year":"2023","unstructured":"Lauder L, Mahfoud F, Azizi M, et al.. Hypertension management in patients with cardiovascular comorbidities. Eur Heart J. 2023, 44:2066-77. 10.1093\/eurheartj\/ehac395","journal-title":"Eur Heart J"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1016\/j.ihj.2022.12.003","article-title":"Prevalence and associated factors of cardiovascular diseases among men and women aged 45 years and above: analysis of the longitudinal ageing study in India, 2017-2019","volume":"75","author":"Kodali NK","year":"2023","unstructured":"Kodali NK, Bhat LD, Phillip NE, Koya SF. Prevalence and associated factors of cardiovascular diseases among men and women aged 45 years and above: analysis of the longitudinal ageing study in India, 2017-2019. Indian Heart J. 2023, 75:31-5. 10.1016\/j.ihj.2022.12.003","journal-title":"Indian Heart J"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.47954","article-title":"Comparison of outcomes between angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with myocardial infarction: a meta-analysis","volume":"15","author":"Escobar J","year":"2023","unstructured":"Escobar J, Rawat A, Maradiaga F, et al.. Comparison of outcomes between angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with myocardial infarction: a meta-analysis. Cureus. 2023, 15:e47954. 10.7759\/cureus.47954","journal-title":"Cureus"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-020-01466-5","article-title":"Assessing the risk of angiotensin receptor blockers on major cardiovascular events: a systematic review and meta-analysis of randomized controlled trials","volume":"20","author":"Wanas Y","year":"2020","unstructured":"Wanas Y, Bashir R, Islam N, Furuya-Kanamori L. Assessing the risk of angiotensin receptor blockers on major cardiovascular events: a systematic review and meta-analysis of randomized controlled trials. BMC Cardiovasc Disord. 2020, 20:188. 10.1186\/s12872-020-01466-5","journal-title":"BMC Cardiovasc Disord"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1097\/01.hjh.0000746472.35950.67","article-title":"Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in stroke prevention: a systematic review and meta-analysis involving 297,451 patients","volume":"39","author":"Alosaimi M","year":"2021","unstructured":"Alosaimi M, Roos NA, Alnakhli AM, Cleland J, Padmanabhan S. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in stroke prevention: a systematic review and meta-analysis involving 297,451 patients. J Hypertension. 2021, 39:184. 10.1097\/01.hjh.0000746472.35950.67","journal-title":"J Hypertension"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0212907","article-title":"Higher versus lower doses of ACE inhibitors, angiotensin-2 receptor blockers and beta-blockers in heart failure with reduced ejection fraction: systematic review and meta-analysis","volume":"14","author":"Turgeon RD","year":"2019","unstructured":"Turgeon RD, Kolber MR, Loewen P, Ellis U, McCormack JP. Higher versus lower doses of ACE inhibitors, angiotensin-2 receptor blockers and beta-blockers in heart failure with reduced ejection fraction: systematic review and meta-analysis. PLoS One. 2019, 14:e0212907. 10.1371\/journal.pone.0212907","journal-title":"PLoS One"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejvs.2022.07.042","article-title":"Effect of Telmisartan on the peak wall stress and peak wall rupture index of small abdominal aortic aneurysms: an exploratory analysis of the Tedy trial","volume":"64","author":"Singh TP","year":"2022","unstructured":"Singh TP, Moxon JV, Gasser TC, et al.. Effect of Telmisartan on the peak wall stress and peak wall rupture index of small abdominal aortic aneurysms: an exploratory analysis of the Tedy trial. Eur J Vasc Endovasc Surg. 2022, 64:396-404. 10.1016\/j.ejvs.2022.07.042","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfab149","article-title":"The Indian Chronic Kidney Disease (ICKD) study: baseline characteristics","volume":"15","author":"Kumar V","year":"2022","unstructured":"Kumar V, Yadav AK, Sethi J, et al.. The Indian Chronic Kidney Disease (ICKD) study: baseline characteristics. Clin Kidney J. 2022, 15:60-9. 10.1093\/ckj\/sfab149","journal-title":"Clin Kidney J"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2369-15-168","article-title":"Observational multicenter study to evaluate the prevalence and prognosis of subclinical atheromatosis in a Spanish chronic kidney disease cohort: baseline data from the NEFRONA study","volume":"15","author":"Arroyo D","year":"2014","unstructured":"Arroyo D, Betriu A, Martinez-Alonso M, Vidal T, Valdivielso JM, Fern\u00e1ndez E. Observational multicenter study to evaluate the prevalence and prognosis of subclinical atheromatosis in a Spanish chronic kidney disease cohort: baseline data from the NEFRONA study. BMC Nephrol. 2014, 15:168. 10.1186\/1471-2369-15-168","journal-title":"BMC Nephrol"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.4093\/dmj.2021.0135","article-title":"Reproductive life span and severe hypoglycemia risk in postmenopausal women with type 2 diabetes mellitus","volume":"46","author":"Kang S","year":"2022","unstructured":"Kang S, Park YM, Kwon DJ, Chung YJ, Namkung J, Han K, Ko SH. Reproductive life span and severe hypoglycemia risk in postmenopausal women with type 2 diabetes mellitus. Diabetes Metab J. 2022, 46:578-91. 10.4093\/dmj.2021.0135","journal-title":"Diabetes Metab J"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfu294","article-title":"Disease burden and risk profile in referred patients with moderate chronic kidney disease: composition of the German Chronic Kidney Disease (GCKD) cohort","volume":"30","author":"Titze S","year":"2015","unstructured":"Titze S, Schmid M, K\u00f6ttgen A, et al.. Disease burden and risk profile in referred patients with moderate chronic kidney disease: composition of the German Chronic Kidney Disease (GCKD) cohort. Nephrol Dial Transplant. 2015, 30:441-51. 10.1093\/ndt\/gfu294","journal-title":"Nephrol Dial Transplant"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.4103\/ijn.IJN_260_20","article-title":"Chronic kidney disease among diabetes and hypertensive patients in a remote rural area of South India: a population-based cross-sectional study","volume":"31","author":"Newtonraj A","year":"2021","unstructured":"Newtonraj A, Tovia S, Girija G, Manikandan M, Vincent A. Chronic kidney disease among diabetes and hypertensive patients in a remote rural area of South India: a population-based cross-sectional study. Indian J Nephrol. 2021, 31:420-2. 10.4103\/ijn.IJN_260_20","journal-title":"Indian J Nephrol"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-020-02199-5","article-title":"Correction to: the impact of hypertension on chronic kidney disease and end-stage renal disease is greater in men than women: a systematic review and meta-analysis","volume":"21","author":"Weldegiorgis M","year":"2020","unstructured":"Weldegiorgis M, Woodward M. Correction to: the impact of hypertension on chronic kidney disease and end-stage renal disease is greater in men than women: a systematic review and meta-analysis. BMC Nephrol. 2020, 21:545. 10.1186\/s12882-020-02199-5","journal-title":"BMC Nephrol"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.13188\/2332-3671.1000028","article-title":"Expert perspectives on the use of cilnidipine in hypertensive patients with diabetic kidney disease in Indian settings","volume":"9","author":"Manjula S","year":"2025","unstructured":"Manjula S. Expert perspectives on the use of cilnidipine in hypertensive patients with diabetic kidney disease in Indian settings. J Cardiobiol. 2025, 9:1. 10.13188\/2332-3671.1000028","journal-title":"J Cardiobiol"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2020.11.003","article-title":"KDIGO 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease","volume":"99","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group","year":"2021","unstructured":"Kidney Disease. Improving Global Outcomes (KDIGO) Blood Pressure Work Group: KDIGO 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int. 2021, 99:S1-S87. 10.1016\/j.kint.2020.11.003","journal-title":"Kidney Int"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.37774","article-title":"Blood pressure reducing potential and renoprotective action of cilnidipine among hypertensive patients suffering from chronic kidney disease: a meta-analysis","volume":"15","author":"Kumari K","year":"2023","unstructured":"Kumari K, Sinha R, Toppo MS, Mishra P, Alam S, Majhee L. Blood pressure reducing potential and renoprotective action of cilnidipine among hypertensive patients suffering from chronic kidney disease: a meta-analysis. Cureus. 2023, 15:e37774. 10.7759\/cureus.37774","journal-title":"Cureus"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1080\/10641963.2018.1445753","article-title":"The effect of an L\/N-type calcium channel blocker on intradialytic blood pressure in intradialytic hypertensive patients","volume":"41","author":"Ito T","year":"2019","unstructured":"Ito T, Fujimoto N, Ishikawa E, et al.. The effect of an L\/N-type calcium channel blocker on intradialytic blood pressure in intradialytic hypertensive patients. Clin Exp Hypertens. 2019, 41:92-9. 10.1080\/10641963.2018.1445753","journal-title":"Clin Exp Hypertens"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.27847","article-title":"Renal function in hypertensive patients receiving cilnidipine and L-type calcium channel blockers: a meta-analysis of randomized controlled and retrospective studies","volume":"14","author":"Srivathsan M","year":"2022","unstructured":"Srivathsan M, Vardhan V, Naseem A, Patil S, Rai V, Langade DG. Renal function in hypertensive patients receiving cilnidipine and L-type calcium channel blockers: a meta-analysis of randomized controlled and retrospective studies. Cureus. 2022, 14:e27847. 10.7759\/cureus.27847","journal-title":"Cureus"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1177\/2050312120973502","article-title":"Renal outcomes of treatment with telmisartan in patients with stage 3-4 chronic kidney disease: A prospective, randomized, controlled trial (JINNAGA)","volume":"8","author":"Kitamura M","year":"2020","unstructured":"Kitamura M, Arai H, Abe S, et al.. Renal outcomes of treatment with telmisartan in patients with stage 3-4 chronic kidney disease: A prospective, randomized, controlled trial (JINNAGA). SAGE Open Med. 2020, 8:2050312120973502. 10.1177\/2050312120973502","journal-title":"SAGE Open Med"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0305223","article-title":"Correlates of diabetes mellitus and hypertension in India: Change as evidenced from NFHS- 4 and 5 during 2015-2021","volume":"19","author":"Rana RK","year":"2024","unstructured":"Rana RK, Jha RR, Sinha R, et al.. Correlates of diabetes mellitus and hypertension in India: Change as evidenced from NFHS- 4 and 5 during 2015-2021. PLoS One. 2024, 19:e0305223. 10.1371\/journal.pone.0305223","journal-title":"PLoS One"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.59556\/japi.72.0620","article-title":"Management of hypertension in patients with type 2 diabetes mellitus: Indian guideline 2024 by Association of Physicians of India and Indian College of Physicians","volume":"72","author":"Wander GS","year":"2024","unstructured":"Wander GS, Panda JK, Pal J, et al.. Management of hypertension in patients with type 2 diabetes mellitus: Indian guideline 2024 by Association of Physicians of India and Indian College of Physicians. J Assoc Physicians India. 2024, 72:e1-e25. 10.59556\/japi.72.0620","journal-title":"J Assoc Physicians India"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.5005\/japi-11001-0048","article-title":"The deadly duo of hypertension and diabetes in India: further affirmation from a new epidemiological study","volume":"71","author":"Metri KG","year":"2023","unstructured":"Metri KG, Raghuram N, S Ram CV, et al.. The deadly duo of hypertension and diabetes in India: further affirmation from a new epidemiological study. J Assoc Physicians India. 2023, 71:P104. 10.5005\/japi-11001-0048","journal-title":"J Assoc Physicians India"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.33545\/26649020.2024.v6.i1a.53","article-title":"Expert perspectives and practices on the clinical use of cilnidipine + telmisartan in the management of hypertension with comorbid diabetes in Indian settings","volume":"6","author":"Manjula S","year":"2024","unstructured":"Manjula S, Krishna KM. Expert perspectives and practices on the clinical use of cilnidipine + telmisartan in the management of hypertension with comorbid diabetes in Indian settings. Int J Cardiol Sci. 2024, 6:74-80. 10.33545\/26649020.2024.v6.i1a.53","journal-title":"Int J Cardiol Sci"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.2337\/dc24-S010","article-title":"Cardiovascular disease and risk management: standards of care in diabetes-2024","volume":"47","author":"American Diabetes Association Professional Practice Committee","year":"2024","unstructured":"American Diabetes Association Professional Practice Committee. Cardiovascular disease and risk management: standards of care in diabetes-2024. Diabetes Care. 2024, 47:S179-218. 10.2337\/dc24-S010","journal-title":"Diabetes Care"},{"key":"ref74","article-title":"Evaluation of Renoprotective Effect of Cilnidipine in Patients with Mild to Moderate Hypertension and Type 2 Diabetes Mellitus - A Prospective Study","volume":"14","author":"Ramya R","year":"2021","unstructured":"Ramya R, Shajahan O, Anakha K. Evaluation of Renoprotective Effect of Cilnidipine in Patients with Mild to Moderate Hypertension and Type 2 Diabetes Mellitus - A Prospective Study. Asian J Pharm Clin Res. 2021, 14:144-6.","journal-title":"Asian J Pharm Clin Res"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfab048","article-title":"Efficacy and safety of combination therapy with sodium-glucose cotransporter 2 inhibitors and renin-angiotensin system blockers in patients with type 2 diabetes: a systematic review and meta-analysis","volume":"37","author":"Tian B","year":"2022","unstructured":"Tian B, Deng Y, Cai Y, Han M, Xu G. Efficacy and safety of combination therapy with sodium-glucose cotransporter 2 inhibitors and renin-angiotensin system blockers in patients with type 2 diabetes: a systematic review and meta-analysis. Nephrol Dial Transplant. 2022, 37:720-9. 10.1093\/ndt\/gfab048","journal-title":"Nephrol Dial Transplant"},{"key":"ref76","article-title":"Effects of high-intensity statin combined with telmisartan versus amlodipine on glucose metabolism in hypertensive atherosclerotic cardiovascular disease patients with impaired fasting glucose: A randomized multicenter trial","volume":"101","author":"Lee CJ","year":"2022","unstructured":"Lee CJ, Sung JH, Kang TS, et al.. Effects of high-intensity statin combined with telmisartan versus amlodipine on glucose metabolism in hypertensive atherosclerotic cardiovascular disease patients with impaired fasting glucose: A randomized multicenter trial. Medicine. 2022, 101:e30496.","journal-title":"Medicine"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.59556\/japi.72.0516","article-title":"Cilnidipine, a dual L\/N-type Ca(2+)","volume":"72","author":"Mehta KK","year":"2024","unstructured":"Mehta KK, Tiwaskar M, Kasture P. Cilnidipine, a dual L\/N-type Ca(2+) . J Assoc Physicians India. 2024, 72:54-8. 10.59556\/japi.72.0516","journal-title":"J Assoc Physicians India"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/5935149","article-title":"Onset of hyperkalemia following the administration of angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker","volume":"2021","author":"Jun HR","year":"2021","unstructured":"Jun HR, Kim H, Lee SH, et al.. Onset of hyperkalemia following the administration of angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker. Cardiovasc Ther. 2021, 2021:5935149. 10.1155\/2021\/5935149","journal-title":"Cardiovasc Ther"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.3390\/cimb46070377","article-title":"The evolving role of calcium channel blockers in hypertension management: pharmacological and clinical considerations","volume":"46","author":"Jones KE","year":"2024","unstructured":"Jones KE, Hayden SL, Meyer HR, et al.. The evolving role of calcium channel blockers in hypertension management: pharmacological and clinical considerations. Curr Issues Mol Biol. 2024, 46:6315-27. 10.3390\/cimb46070377","journal-title":"Curr Issues Mol Biol"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.39098","article-title":"Hypertension diagnosis, treatment, and control in India","volume":"6","author":"Varghese JS","year":"2023","unstructured":"Varghese JS, Venkateshmurthy NS, Sudharsanan N, et al.. Hypertension diagnosis, treatment, and control in India. JAMA Netw Open. 2023, 6:e2339098. 10.1001\/jamanetworkopen.2023.39098","journal-title":"JAMA Netw Open"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/5749648","article-title":"Qualitative study of barriers to adherence to antihypertensive medication among rural women in India","volume":"2019","author":"Gupta S","year":"2019","unstructured":"Gupta S, Dhamija JP, Mohan I, Gupta R. Qualitative study of barriers to adherence to antihypertensive medication among rural women in India. Int J Hypertens. 2019, 2019:5749648. 10.1155\/2019\/5749648","journal-title":"Int J Hypertens"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1097\/01.hjh.0001019828.97610.6c","article-title":"Systematic review of medication adherence in patients with hypertension in India","volume":"42","author":"Agarwal A","year":"2024","unstructured":"Agarwal A, Osman H, Patel P, Mathur SK, Bernieh D, Gupta P. Systematic review of medication adherence in patients with hypertension in India. J Hypertens. 2024, 42:59. 10.1097\/01.hjh.0001019828.97610.6c","journal-title":"J Hypertens"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1016\/j.ihj.2023.12.009","article-title":"Comparison of Indian clinical practice guidelines for the management of hypertension with the World Health Organization, International Society of Hypertension, American, and European guidelines","volume":"76","author":"Satheesh G","year":"2024","unstructured":"Satheesh G, Dhurjati R, Balagopalan JP, Mohanan PP, Salam A. Comparison of Indian clinical practice guidelines for the management of hypertension with the World Health Organization, International Society of Hypertension, American, and European guidelines. Indian Heart J. 2024, 76:6-9. 10.1016\/j.ihj.2023.12.009","journal-title":"Indian Heart J"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/430965-hypertension-management-beyond-blood-pressure-control-in-india-an-expert-consensus-on-angiotensin-ii-receptor-blocker-and-calcium-channel-blocker-combination-therapy-with-reference-to-telmisartan-and-cilnidipine","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T05:52:09Z","timestamp":1770702729000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/430965-hypertension-management-beyond-blood-pressure-control-in-india-an-expert-consensus-on-angiotensin-ii-receptor-blocker-and-calcium-channel-blocker-combination-therapy-with-reference-to-telmisartan-and-cilnidipine"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,9]]},"references-count":83,"URL":"https:\/\/doi.org\/10.7759\/cureus.103320","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,9]]}}}